< Back to companies
Earli

Earli

San Francisco, California, United States

Earli is developing a radically new technique originally from Stanford University. Instead of searching, we force cancer cells to produce synthetic biomarkers that do not belong in the human body, which are then highly detectable and localizable in a PET scanner. We use biology for this, not chemistry, which allows for massive signal amplification. And the same technique also allows us to ultimately destroy the cancer.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2018
Website
www.earli.com/

Categories

CancerPrecision Medicine/Diagnostics
Only accessible to MedStartr community members. Join now

What do you think of Earli?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now